Stay updated on Nivolumab After SIRT for HCC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab After SIRT for HCC Clinical Trial page.

Latest updates to the Nivolumab After SIRT for HCC Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedAdded Hepatocellular carcinoma to the site taxonomy and introduced a new Resources entry for the Genetic and Rare Diseases Information Center. Updated the revision from v3.4.3 to v3.5.0.SummaryDifference0.2%

- Check27 days agoChange DetectedSite revision updated to v3.4.3, replacing v3.4.2.SummaryDifference0.1%

- Check56 days agoChange DetectedRevision: v3.4.2 was added and the previous funding-status notice v3.4.1 was removed. The study details and page content remain unchanged; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check63 days agoChange DetectedA site-wide government funding notice was added at the top of the page, clarifying possible delays and directing users to cc.nih.gov and opm.gov, and the page revision was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check70 days agoChange DetectedShow glossary has been added, along with labels such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' and a site revision note 'Revision: v3.4.0'. The previous labels 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data' and revision note 'Revision: v3.3.4' were removed.SummaryDifference0.2%

- Check84 days agoChange DetectedRevision: v3.3.4 was added and the previous Revision: v3.3.3 was removed.SummaryDifference0.1%

Stay in the know with updates to Nivolumab After SIRT for HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab After SIRT for HCC Clinical Trial page.